Unexpected antibody against the high-prevalence P antigen before cardiac surgery

1Scharberg EA, Olsen C, Bugert P. The H blood group system. Immunohematology 2016;32:112–8. Scharberg EA Olsen C Bugert P The H blood group system Immunohematology 201632112 810.21307/immunohematology-2019-056Search in Google Scholar

2Daniels G. Human blood groups. Oxford, U.K.: Blackwell Scientific, 2002. Daniels G Human blood groups Oxford, U.K Blackwell Scientific 200210.1002/9780470987018Search in Google Scholar

3Spitalnik PF, Spitalnik SL. The P blood group system: biochemical, serological, and clinical aspects. Transfus Med Rev 1995;9:110–22. Spitalnik PF Spitalnik SL The P blood group system: biochemical, serological, and clinical aspects Transfus Med Rev 19959110 2210.1016/S0887-7963(05)80050-1Search in Google Scholar

4Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006;46:630–5. Schonewille H van de Watering LM Brand A Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 200646630 510.1111/j.1537-2995.2006.00764.x16584440Search in Google Scholar

5Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009;49:453–7. Schonewille H de Vries RR Brand A Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients Transfusion 200949453 710.1111/j.1537-2995.2008.01980.x19243541Search in Google Scholar

6Hellberg A, Poole J, Olsson ML. Molecular basis of the Globoside-deficient Pk blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002;277: 29455–9. Hellberg A Poole J Olsson ML Molecular basis of the Globoside-deficient Pk blood group phenotype Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002277 29455 910.1074/jbc.M20304720012023287Search in Google Scholar

7Cedergren B. Population studies in northern Sweden. IV. Frequency of the blood type P. Hereditas 1973;73:27–30. Cedergren B Population studies in northern Sweden IV. Frequency of the blood type P. Hereditas 19737327 3010.1111/j.1601-5223.1973.tb01063.xSearch in Google Scholar

8Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304–16. Daniels GL Fletcher A Garratty G et al Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens Vox Sang 200487304 1610.1111/j.1423-0410.2004.00564.x15585029Search in Google Scholar

9Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: incidental receptors for viruses and bacteria. J Transfus 1996;36:362–74. Moulds JM Nowicki S Moulds JJ Nowicki BJ Human blood groups: incidental receptors for viruses and bacteria J Transfus 199636362 7410.1046/j.1537-2995.1996.36496226154.x8623141Search in Google Scholar

10Lindström K, Von Dem Borne AE, Breimer ME, et al. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women: evidence for placenta being the primary target for anti-Tja-antibodies. Glycoconj J 1992;9:325–9. Lindström K Von Dem Borne AE Breimer ME et al Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women: evidence for placenta being the primary target for anti-Tja-antibodies Glycoconj J 19929325 910.1007/BF007310931305424Search in Google Scholar

11Hagman JR, Hult AK, Westman JS, et al. Multiple miscarriages in two sisters of Thai origin with the rare Pk phenotype caused by a novel nonsense mutation at the B3GALNT1 locus. Transfus Med 2019;29:202–8. Hagman JR Hult AK Westman JS et al Multiple miscarriages in two sisters of Thai origin with the rare Pk phenotype caused by a novel nonsense mutation at the B3GALNT1 locus Transfus Med 201929202 810.1111/tme.1254429873420Search in Google Scholar

12Prince SD, Winestone LE, Nance SJ, Friedman DF. Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report. Transfusion 2017;57:1401–6. Prince SD Winestone LE Nance SJ Friedman DF Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report Transfusion 2017571401 610.1111/trf.14032573377828369934Search in Google Scholar

13Westman JS, Benktander J, Storry JR, et al. Identification of the molecular and genetic basis of PX2, a glycosphingolipid blood group antigen lacking on globoside-deficient erythrocytes. J Biol Chem 2015;290:18505–18. Westman JS Benktander J Storry JR et al Identification of the molecular and genetic basis of PX2, a glycosphingolipid blood group antigen lacking on globoside-deficient erythrocytes J Biol Chem 201529018505 1810.1074/jbc.M115.655308451311126055721Search in Google Scholar

14Chang A, Kim Y, Hoehn R, Jernigan, Pritts T. Cryopreserved packed red blood cells in surgical patients: past, present, and future. Blood Transfus 2017;15:341–7. Chang A Kim Y Hoehn R Jernigan Pritts T Cryopreserved packed red blood cells in surgical patients: past, present, and future Blood Transfus 201715341 7Search in Google Scholar

15Cap A, Badloe J, Woolley T, et al. The use of frozen and deglycerolized red blood cells. Mil Med 2018;18:10–52. Cap A Badloe J Woolley T et al The use of frozen and deglycerolized red blood cells Mil Med 20181810 5210.1093/milmed/usy06130189057Search in Google Scholar

16Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nature Rev Drug Discov 2019;18:707–29. Mastellos DC Ricklin D Lambris JD Clinical promise of next-generation complement therapeutics Nature Rev Drug Discov 201918707 2910.1038/s41573-019-0031-6734085331324874Search in Google Scholar

17Franchini M, Marano G, Veropalumbo E, et al. Patient blood management: a revolutionary approach to transfusion medicine. Blood Transfus 2019;17:191–5. Franchini M Marano G Veropalumbo E et al Patient blood management: a revolutionary approach to transfusion medicine Blood Transfus 201917191 5Search in Google Scholar

18Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017;57:1347–58. Leahy MF Hofmann A Towler S et al Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals Transfusion 2017571347 5810.1111/trf.1400628150313Search in Google Scholar